What the buyer needs
AI summaryHealth Canada requires high-throughput genome sequencing services for pre-prepared DNA libraries and genomic DNA/RNA. The services will utilize Illumina and Pacific Biosciences (PacBio) platforms to investigate how chemical substances cause DNA damage leading to illnesses like cancer. The primary objective is to secure long-term, high-quality sequencing services for projects funded until up to 2030-2031. This encompasses sequencing of mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA, and/or RNA samples. The work will use ecNGS, whole-genome sequencing (WGS), whole-exome sequencing, and/or RNA-sequencing approaches. The goal is to detect and characterize mutations and gene expression changes in mouse and human DNA to understand mutagenic mechanisms and improve genetic toxicology assessments.
